Skip to content
Governance Register

← US public companies

Global Blood Therapeutics, Inc.

SEC CIK 1629137 · GBT · last insider filing 2022-10-06

Directors (from insider filings)

NameCapacity as filedFilings
Patrick Deval L Director filed 2015 - 2022
Yarno Wendy L Director filed 2017 - 2022
Love TED W Director · See Remarks. filed 2015 - 2022
Perry Mark L Director filed 2015 - 2022
Pierce Glenn Director filed 2016 - 2022
Pizzo Philip A. Director filed 2015 - 2022
Svoronos Dawn Director filed 2018 - 2022
Morrison Scott W Director filed 2016 - 2022
Thompson Alexis A. Director filed 2021 - 2022
Brown Willie L. Jr. Director filed 2015 - 2021
Homcy Charles J Director filed 2015 - 2018
Starr Kevin P Director filed 2015 - 2017
Bonney Michael W Director filed 2016 - 2016

Officers (from insider filings)

NameTitle as filedFilings
Suvari Tricia Borga Chief Legal Officer filed 2016 - 2022
Farrow Jeffrey S Chief Financial Officer filed 2016 - 2022
Choi Jung See Remarks filed 2015 - 2022
Johnson David LEE Chief Commercial Officer filed 2018 - 2022
Krehlik Carrie Chief Human Resources Officer filed 2021 - 2022
Smith-Whitley Kim See Remarks filed 2021 - 2022
Habibizad Nazila See Remarks filed 2022 - 2022
Fink Eric Chief Human Resources Officer filed 2019 - 2021
Cathers Brian Edwin See Remarks filed 2019 - 2021
Calhoun Lesley Ann See Remarks filed 2018 - 2020
Lehrer-Graiwer Joshua Chief Medical Officer filed 2019 - 2020
Sham Hing Senior VP, Research filed 2015 - 2018
Radovich Peter Senior VP, Operations filed 2015 - 2018
Ramos Eleanor Chief Medical Officer filed 2015 - 2016
Schembri John See Remarks filed 2015 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.